← All research updates

Chemo may switch on repair signals in brain tumors

Original title: Temozolomide-associated inflammatory-repair remodeling in recurrent glioblastoma exposes a ROCK-linked therapeutic vulnerability

How far along is this research?

This is a preprint. Other scientists have not checked it yet, so treat it as an early signal rather than an answer.

The drug pair only helped mice live longer, not people.

The short version

Adding a drug called fasudil to chemo helped mice with glioblastoma: A glioma that is given grade 4, the highest grade. It grows fast. Treatment usually starts soon after it is found. It often means surgery, then radiation and chemotherapy. See the glossary live longer.

What was studied. Researchers compared tumors from seven people whose glioblastoma: A glioma that is given grade 4, the highest grade. It grows fast. Treatment usually starts soon after it is found. It often means surgery, then radiation and chemotherapy. See the glossary came back. Four had extra chemo before surgery, and three did not.

What they found. Tumors that got extra chemo showed more signs of swelling and wound repair. In lab tests, a drug called fasudil calmed those signals. In three mouse models, fasudil plus chemo helped mice live longer.

What this means, and what it doesn't

What it could mean: Chemo may set off changes that help tumor cells repair and move. Blocking those changes might help chemo work better. Fasudil is not a brain tumor treatment today.

What it doesn't mean: This does not mean fasudil helps people with glioblastoma: A glioma that is given grade 4, the highest grade. It grows fast. Treatment usually starts soon after it is found. It often means surgery, then radiation and chemotherapy. See the glossary. The longer survival was seen in mice, not in people. The human part only looked at tumor tissue from seven people. This is early work, and it is not a promise of a cure.

Source: bioRxiv (preprint), September 22, 2026 · Read the original

This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.

Report a problem with this summary